相关实验视频

Updated: Jun 15, 2025

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

5.4K

替代标记物和临床结果-回复

Joshua D Wallach1, Reshma Ramachandran2, Joseph S Ross2,3

  • 1Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia.

JAMA
|August 21, 2024
PubMed
概括

No abstract available in PubMed .

更多相关视频

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.2K
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

18.6K

相关实验视频

Last Updated: Jun 15, 2025

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

5.4K
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.2K
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

18.6K

相关概念视频

Kaplan-Meier Approach01:24

Kaplan-Meier Approach

115
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
115
Cancer Survival Analysis01:21

Cancer Survival Analysis

334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334

通过共同作者、期刊和引用图与本文相关的文章。

Physician Network Connections Associated With Faster De-Adoption of Dronedarone for Permanent Atrial Fibrillation.

Circulation. Cardiovascular quality and outcomes·2021

Implementation of 21st Century Cures Act Expanded Access Policies Requirements.

Clinical pharmacology and therapeutics·2021

Uptake of evidence by physicians: De-adoption of erythropoiesis-stimulating agents after the TREAT trial.

BMC nephrology·2021

Characteristics of available studies and dissemination of research using major clinical data sharing platforms.

Clinical trials (London, England)·2021

The Association Between History of Depression and Access to Care Among Medicare Beneficiaries During the COVID-19 Pandemic.

Journal of general internal medicine·2021

Second-Line Therapy for Type 2 Diabetes Management: The Treatment/Benefit Paradox of Cardiovascular and Kidney Comorbidities.

Diabetes care·2021

Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment.

JAMA·2026

Ceperognastat in Early Symptomatic Alzheimer Disease: A Randomized Clinical Trial.

JAMA·2026

Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis.

JAMA·2026

Clinicopathologic Evaluation of Amyloid Clearance in Alzheimer Disease.

JAMA·2026

YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism in Patients With Cancer: A Randomized Clinical Trial.

JAMA·2026

Testing the Generalizability of the Priority Heuristic to Two-Stage Decision Making Tasks: A Comparison to Quantum Cognition and Prospect Theory.

Computational brain & behavior·2026

A Sequential Sampling Approach to the Integration of Habits and Goals.

Computational brain & behavior·2026

How Sure is the Driver? Modelling Drivers' Confidence in Left-Turn Gap Acceptance Decisions.

Computational brain & behavior·2026

Confidence Is Influenced by Evidence Accumulation Time in Dynamical Decision Models.

Computational brain & behavior·2026

The predictive-affective loop for directors: a target-state design framework for audiovisual directing.

Frontiers in psychology·2026

Testing Principles of Choice in Categorization.

Computational brain & behavior·2026
查看所有相关文章
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策
Jove
Visualize
联系我们